Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
EVE Health Group Limited has requested a trading halt for its securities, effective immediately, pending an announcement regarding a capital raising. The halt will remain in effect until normal trading resumes or the announcement is made, whichever comes first. The company has stated that it is not aware of any reasons why the trading halt should not be granted by the ASX.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-1451
EVE Health Group Limited on 6ix
Earlier from EVE Health
- EVE Advances Reformulated Drugs Targeting Global Markets
- Appendix 4D and Half Year Report
- Launch of Libbo and Activation of Men's Health Platform
- Quarterly Activities/Appendix 4C Cash Flow Report
- EVE Completes Initial Production of Libbo
Later from EVE Health
- EVE Raises $0.9m to Advance Drug Reformulation Strategy
- EVE Placement Update
- Prospectus
- Investor Presentation
- Appointment of Chief Executive Officer
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health